[Sequential measurement of serum CA 125 levels in Krukenberg's tumor].
CA 125 is a tumor marker for ovarian cancer developed by hybridoma technology. In the present study, the levels of CA 125 were sequentially measured in the serum of five patients with Krukenberg's tumor originating in the gastrointestinal tract. Four out of the five (80%) had elevated serum CA 125 levels, i.e., greater than 35 U/ml and, in most cases, these levels decreased after resection of the ovarian tumor. Serum CA 19-9 and CEA levels were also increased in two (40%) and three (60%) patients, respectively, and, in these positive cases, reflected the clinical course. The results indicated the clinical usefulness of these cancer markers in Krukenberg's tumor.
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D003110:Colonic Neoplasms / Q000473:pathology; D005260:Female; D005743:Gastrectomy; D006801:Humans; D007725:Krukenberg Tumor / Q000276:immunology* / Q000556:secondary; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000556:secondary; D013274:Stomach Neoplasms / Q000473:pathology
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate